Literature DB >> 4670496

Interaction of a new cephalosporin, 7-cyanacetamidocephalosporanic acid, with some gram-negative and gram-positive beta-lactamase-producing bacteria.

A D Russel.   

Abstract

When gram-negative beta-lactamase-producing bacteria were incubated at 37 C in broth containing 100 to 250 mug or more of 7-cyanacetamidocephalosporanic acid (CAA) per ml, a red or orange color developed, irrespective of whether or not growth had occurred. This color development was paralleled by breakdown of CAA by Escherichia coli R(+)TEM, although there was a concurrent lethal effect on the cells. No red color developed with gram-positive or gram-negative strains that did not produce beta-lactamase. Several methicillin-susceptible beta-lactamase-producing strains of Staphylococcus aureus produced a faint red color, as did one of four penicillin acylase-producing E. coli strains. No color resulted when two methicillin-resistant, beta-lactamase-nonproducing S. aureus strains were tested. Two methicillin-resistant, beta-lactamase-producing S. aureus strains produced a bright red color at 37 C, but a much fainter one at 30 C.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4670496      PMCID: PMC444302          DOI: 10.1128/AAC.2.4.255

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  SYNERGISTIC ACTION OF PENICILLINS AND CEPHALOSPORINS AGAINST PSEUDOMONAS PYOCYANEA.

Authors:  L D SABATH; E P ABRAHAM
Journal:  Nature       Date:  1964-12-12       Impact factor: 49.962

2.  Penicillinase production and intrinsic resistance to penicillins in methicillin-resistant cultures of Staphylococcus aureus.

Authors:  K G Dyke
Journal:  J Med Microbiol       Date:  1969-08       Impact factor: 2.472

3.  The effect of temperature on resistance of Staphylococcus aureus to methicillin and some other antibioics.

Authors:  D I Annear
Journal:  Med J Aust       Date:  1968-03-16       Impact factor: 7.738

4.  Antimicrobial studies in vitro with CIBA 36278-Ba, a new cephalosporin derivative.

Authors:  F Knüsel; E A Konopka; J Gelzer; A Rosselet
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1970
  4 in total
  7 in total

1.  Multicentre comparison of cephacetrile and ampicillin in the treatment of urinary tract infections.

Authors:  C Ponticelli; P Zucchelli; G Casucci; I Cervellati; C Dalla Rosa; C Giro; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

Review 2.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

3.  In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.

Authors:  R N Jones; H W Wilson; W J Novick; A L Barry; C Thornsberry
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

4.  In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds.

Authors:  R N Jones; H W Wilson; W J Novick
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

5.  Pharmacokinetic studies in animals and humans of a new cephalosporin, the sodium salt of 7-cyanacetamidocephalosporanic acid.

Authors:  D K Luscombe; P J Nicholls; D R Owens; A D Russell
Journal:  Antimicrob Agents Chemother       Date:  1973-06       Impact factor: 5.191

6.  Effect of ethylenediaminetetraacetic acid and related chelating agents on whole cells of gram-negative bacteria.

Authors:  H Haque; A D Russell
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

7.  Isolation and determination of four potential antimicrobial components from Pseudomonas aeruginosa extracts.

Authors:  Ling-Qing Xu; Jian-Wen Zeng; Chong-He Jiang; Huan Wang; Yu-Zhen Li; Wei-Hong Wen; Jie-Hua Li; Feng Wang; Wei-Jen Ting; Zi-Yong Sun; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.